Diabetes Medications and Heart Failure Recognizing the Risk

被引:20
作者
Fonarow, Gregg C. [1 ]
机构
[1] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA
关键词
Editorials; diabetes mellitus; heart failure; hospitalization; treatment outcome; MYOCARDIAL DIASTOLIC FUNCTION; GLYCEMIC CONTROL; GLUCOSE CONTROL; TYPE-2; INHIBITORS; PERFUSION; MELLITUS; OUTCOMES; TRIAL;
D O I
10.1161/CIRCULATIONAHA.114.012883
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1565 / 1567
页数:3
相关论文
共 20 条
[1]   Dipeptidyl Peptidase-4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow-Mediated Vasodilatation in Type 2 Diabetic Patients [J].
Ayaori, Makoto ;
Iwakami, Naotsugu ;
Uto-Kondo, Harumi ;
Sato, Hiroki ;
Sasaki, Makoto ;
Komatsu, Tomohiro ;
Iizuka, Maki ;
Takiguchi, Shunichi ;
Yakushiji, Emi ;
Nakaya, Kazuhiro ;
Yogo, Makiko ;
Ogura, Masatsune ;
Takase, Bonpei ;
Murakami, Takehiko ;
Ikewaki, Katsunori .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (01) :e003277
[2]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[3]   Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].
Duckworth, William ;
Abraira, Carlos ;
Moritz, Thomas ;
Reda, Domenic ;
Emanuele, Nicholas ;
Reaven, Peter D. ;
Zieve, Franklin J. ;
Marks, Jennifer ;
Davis, Stephen N. ;
Hayward, Rodney ;
Warren, Stuart R. ;
Goldman, Steven ;
McCarren, Madeline ;
Vitek, Mary Ellen ;
Henderson, William G. ;
Huang, Grant D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62
[4]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[5]   Renal and Cardiac Effects of DPP-4 Inhibitors - from Preclinical Development to Clinical Research [J].
Hocher, Berthold ;
Reichetzeder, Christoph ;
Alter, Markus L. .
KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01) :65-84
[6]   Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes [J].
Holman, Rury R. ;
Sourij, Harald ;
Califf, Robert M. .
LANCET, 2014, 383 (9933) :2008-2017
[7]  
Iribarren C, 2001, CIRCULATION, V103, P2668
[8]   A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes metlitus And Diastolic Dysfunction) study [J].
Jarnert, Christina ;
Landstedt-Hallin, Lena ;
Malmberg, Klas ;
Melcher, Anders ;
Ohrvik, John ;
Persson, Hans ;
Ryden, Lars .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (01) :39-47
[9]   ROLE OF DIABETES IN CONGESTIVE HEART-FAILURE - FRAMINGHAM STUDY [J].
KANNEL, WB ;
HJORTLAND, M ;
CASTELLI, WP .
AMERICAN JOURNAL OF CARDIOLOGY, 1974, 34 (01) :29-34
[10]  
McMurray J., 2013, HEART FAIL C 2013 MA